Clinical trial
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus…
NCT00257556 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00257556 |
|---|---|
| Title | A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa |
| Official title | A Prospective, Open Label, Randomised, Parallel Group, Comparative Pilot Study to Study the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant FSH (Follitropin Alfa) Administered Subcutaneously to Subfertile Female Patients Undergoing IVF Using Antagonist Downregulation |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | Menotrophin, Follitropin alfa |
| Enrollment | 80 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Nov 23, 2005 |
| Last update posted | Feb 26, 2010 |
| Countries | Germany, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: